IDH3A Antikörper
-
- Target Alle IDH3A Antikörper anzeigen
- IDH3A (Isocitrate Dehydrogenase 3 (NAD+) alpha (IDH3A))
-
Reaktivität
- Human, Ratte, Maus, Hund
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser IDH3A Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunohistochemistry (IHC)
- Aufreinigung
- Purified
- Immunogen
- IDH3 A antibody was raised using a synthetic peptide corresponding to a region with amino acids MKIFDAAKAPIQWEERNVTAIQGPGGKWMIPSEAKESMDKNKMGLKGPLK
- Top Product
- Discover our top product IDH3A Primärantikörper
-
-
- Applikationshinweise
-
WB: 1.25 µg/mL, IHC: 4-8 µg/mL
Optimal conditions should be determined by the investigator. - Kommentare
-
IDH3A Blocking Peptide, catalog no. 33R-6142, is also available for use as a blocking control in assays to test for specificity of this IDH3A antibody
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of IDH0 antibody in PBS
- Konzentration
- Lot specific
- Buffer
- PBS
- Handhabung
- Avoid repeated freeze/thaw cycles.
- Lagerung
- 4 °C/-20 °C
- Informationen zur Lagerung
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
- Target
- IDH3A (Isocitrate Dehydrogenase 3 (NAD+) alpha (IDH3A))
- Andere Bezeichnung
- IDH3A (IDH3A Produkte)
- Synonyme
- idh3a antikoerper, MGC76128 antikoerper, IDH3A antikoerper, zgc:56380 antikoerper, zgc:85631 antikoerper, BG1 antikoerper, 1110003P10Rik antikoerper, 1500012E04Rik antikoerper, AA407078 antikoerper, AI316514 antikoerper, isocitrate dehydrogenase 3 (NAD+) alpha antikoerper, isocitrate dehydrogenase 3 (NAD(+)) alpha antikoerper, isocitrate dehydrogenase 3 (NAD+) alpha S homeolog antikoerper, idh3a antikoerper, IDH3A antikoerper, idh3a.S antikoerper, Idh3a antikoerper
- Hintergrund
- Isocitrate dehydrogenases catalyze the oxidative decarboxylation of isocitrate to 2-oxoglutarate. These enzymes belong to two distinct subclasses, one of which utilizes NAD(+) as the electron acceptor and the other NADP(+). Five isocitrate dehydrogenases have been reported: three NAD(+)-dependent isocitrate dehydrogenases, which localize to the mitochondrial matrix, and two NADP(+)-dependent isocitrate dehydrogenases, one of which is mitochondrial and the other predominantly cytosolic. NAD(+)-dependent isocitrate dehydrogenases catalyze the allosterically regulated rate-limiting step of the tricarboxylic acid cycle. Each isozyme is a heterotetramer that is composed of two alpha subunits, one beta subunit, and one gamma subunit.
- Molekulargewicht
- 40 kDa (MW of target protein)
-